Siga Technologies Net Profit Margin 2006-2020 | SIGA

Siga Technologies net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Siga Technologies Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.06B $0.01B 10.91%
2020-03-31 $0.02B $-0.02B -94.74%
2019-12-31 $0.03B $-0.01B -26.92%
2019-09-30 $0.02B $0.05B 208.33%
2019-06-30 $0.49B $0.44B 90.14%
2019-03-31 $0.49B $0.44B 89.51%
2018-12-31 $0.48B $0.42B 88.08%
2018-09-30 $0.48B $0.36B 75.26%
2018-06-30 $0.01B $-0.04B -557.14%
2018-03-31 $0.01B $-0.04B -500.00%
2017-12-31 $0.01B $-0.04B -336.36%
2017-09-30 $0.02B $-0.04B -217.65%
2017-06-30 $0.02B $-0.04B -171.43%
2017-03-31 $0.02B $-0.04B -200.00%
2016-12-31 $0.02B $-0.04B -260.00%
2016-09-30 $0.01B $-0.05B -408.33%
2016-06-30 $0.01B $-0.05B -575.00%
2016-03-31 $0.01B $-0.04B -614.29%
2015-12-31 $0.01B $-0.04B -571.43%
2015-09-30 $0.00B $-0.04B -975.00%
2015-06-30 $0.00B $-0.27B -6825.00%
2015-03-31 $0.00B $-0.27B -6725.00%
2014-12-31 $0.00B $-0.27B -6625.00%
2014-09-30 $0.00B $-0.25B -6250.00%
2014-06-30 $0.01B $-0.02B -300.00%
2014-03-31 $0.01B $-0.02B -300.00%
2013-12-31 $0.01B $-0.02B -340.00%
2013-09-30 $0.01B $-0.02B -228.57%
2013-06-30 $0.01B $-0.01B -200.00%
2013-03-31 $0.01B $-0.02B -166.67%
2012-12-31 $0.01B $-0.02B -166.67%
2012-09-30 $0.01B $-0.00B -18.18%
2012-06-30 $0.01B $0.00B 7.69%
2012-03-31 $0.01B $0.03B 241.67%
2011-12-31 $0.01B $0.03B 223.08%
2011-09-30 $0.01B $-0.02B -154.55%
2011-06-30 $0.01B $-0.02B -150.00%
2011-03-31 $0.02B $-0.05B -312.50%
2010-12-31 $0.02B $-0.05B -263.16%
2010-09-30 $0.02B $-0.02B -75.00%
2010-06-30 $0.02B $-0.01B -70.59%
2010-03-31 $0.02B $-0.02B -100.00%
2009-12-31 $0.01B $-0.02B -135.71%
2009-09-30 $0.01B $-0.02B -175.00%
2009-06-30 $0.01B $-0.02B -230.00%
2009-03-31 $0.01B $-0.02B -200.00%
2008-12-31 $0.01B $-0.01B -125.00%
2008-09-30 $0.01B $-0.01B -100.00%
2008-06-30 $0.01B $-0.01B -87.50%
2008-03-31 $0.01B $-0.00B -42.86%
2007-12-31 $0.01B $-0.01B -71.43%
2007-09-30 $0.01B $-0.01B -114.29%
2007-06-30 $0.01B $-0.01B -100.00%
2007-03-31 $0.01B $-0.01B -142.86%
2006-12-31 $0.01B $-0.01B -166.67%
2006-09-30 $0.01B $-0.01B -100.00%
2006-06-30 $0.01B $-0.00B -57.14%
2006-03-31 $0.01B $-0.00B -50.00%
2005-12-31 $0.01B $-0.00B -25.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.511B $0.027B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.589B 43.56
Takeda Pharmaceutical (TAK) Japan $50.286B 9.38
Astellas Pharma (ALPMY) Japan $25.898B 0.00
Eisai (ESALY) Japan $23.767B 20.08
UCB SA (UCBJF) Belgium $20.005B 0.00
Merck (MKGAF) Germany $19.897B 26.09
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $14.706B 47.80
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 24.18
Grifols, S.A (GRFS) Spain $11.592B 14.17
Neurocrine Biosciences (NBIX) United States $9.225B 35.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.076B 13.36
IPSEN SA ADR (IPSEY) France $7.465B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.545B 41.46
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $5.942B 0.00
United Therapeutics (UTHR) United States $5.788B 12.32
Evotec AG (EVTCY) Germany $4.416B 142.16
Sage Therapeutics (SAGE) United States $3.841B 0.00
PTC Therapeutics (PTCT) United States $3.649B 0.00
FibroGen (FGEN) United States $3.525B 0.00
ChemoCentryx (CCXI) United States $3.412B 0.00
Hypermarcas (HYPMY) Brazil $3.142B 11.56
Nektar Therapeutics (NKTR) United States $2.900B 0.00
Pacira BioSciences (PCRX) United States $2.270B 50.11
Taro Pharmaceutical Industries (TARO) Israel $2.251B 11.49
Xencor (XNCR) United States $2.243B 0.00
Revolution Medicines (RVMD) United States $2.079B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.026B 0.00
Corcept Therapeutics (CORT) United States $1.983B 18.25
Cronos Group (CRON) Canada $1.949B 0.00
USANA Health Sciences (USNA) United States $1.653B 14.56
Ironwood Pharmaceuticals (IRWD) United States $1.539B 10.69
Heron Therapeutics (HRTX) United States $1.457B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.307B 12.46
Trillium Therapeutics (TRIL) Canada $1.261B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.232B 0.00
Zogenix (ZGNX) United States $1.182B 0.00
Karyopharm Therapeutics (KPTI) United States $1.146B 0.00
Endo (ENDP) Ireland $1.087B 1.61
Indivior (INVVY) United States $1.031B 12.78
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $1.005B 0.00
ImmunoGen (IMGN) United States $0.988B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.882B 549.00
Esperion Therapeutics (ESPR) United States $0.873B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Tilray (TLRY) Canada $0.759B 0.00
Ocular Therapeutix (OCUL) United States $0.677B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.659B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
Radius Health (RDUS) United States $0.640B 0.00
Collegium Pharmaceutical (COLL) United States $0.623B 0.00
Flexion Therapeutics (FLXN) United States $0.589B 0.00
VAXART, INC (VXRT) United States $0.580B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.569B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.510B 0.00
Aerie Pharmaceuticals (AERI) United States $0.502B 0.00
Molecular Templates (MTEM) United States $0.474B 0.00
Ardelyx (ARDX) United States $0.466B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.426B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.410B 0.00
Organogenesis Holdings (ORGO) United States $0.385B 0.00
Harpoon Therapeutics (HARP) United States $0.380B 0.00
Altimmune (ALT) United States $0.376B 0.00
TherapeuticsMD (TXMD) United States $0.359B 0.00
DURECT (DRRX) United States $0.353B 0.00
Profound Medical (PROF) Canada $0.341B 0.00
Redhill Biopharma (RDHL) Israel $0.327B 0.00
Akebia Therapeutics (AKBA) United States $0.325B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.322B 7.97
Concert Pharmaceuticals (CNCE) United States $0.319B 0.00
KalVista Pharmaceuticals (KALV) United States $0.308B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
MEI Pharma (MEIP) United States $0.299B 0.00
Jounce Therapeutics (JNCE) United States $0.297B 14.05
Innate Pharma SA (IPHYF) France $0.291B 0.00
Menlo Therapeutics (VYNE) United States $0.288B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Lannett Co Inc (LCI) United States $0.259B 6.02
Calithera Biosciences (CALA) United States $0.253B 0.00
CASI Pharmaceuticals (CASI) United States $0.239B 0.00
CTI BioPharma (CTIC) United States $0.233B 0.00
Xeris Pharmaceuticals (XERS) United States $0.228B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.223B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 20.98
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Aduro Biotech (KDNY) United States $0.193B 0.00
Nivalis Therapeutics (ALPN) United States $0.183B 0.00
Otonomy (OTIC) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.175B 0.00
Heat Biologics (HTBX) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.163B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.162B 0.00
OptiNose (OPTN) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.112B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
MediWound (MDWD) Israel $0.091B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Lipocine (LPCN) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.080B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.077B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Biomerica (BMRA) United States $0.066B 0.00
ElectroCore (ECOR) United States $0.065B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.065B 0.00
Novan (NOVN) United States $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Addex Therapeutics (ADXN) Switzerland $0.060B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 27.36
Forward Pharma (FWP) Denmark $0.044B 0.00
Recro Pharma (REPH) United States $0.040B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.034B 8.67
GTx (ONCT) United States $0.031B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.030B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.030B 0.00
IsoRay (ISR) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Cyanotech (CYAN) United States $0.018B 26.59
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sundial Growers (SNDL) Canada $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Bio-Path Holdings (BPTH) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00